Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404257 · ClinicalTrials.gov registry record · NA
Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
A NA study of Radiation Exposure and Cardiac Catheterization, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT04404257: Completed NA study of Radiation Exposure and Cardiac Catheterization, sponsored by Corewell Health East.
NCT04404257 is a NA study of Radiation Exposure and Cardiac Catheterization that has completed, run by Corewell Health East. The registered enrollment target is 170 participants, above the 26-participant average among 7 other Radiation Exposure trials with a reported enrollment target (554% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404257, a NA study of Radiation Exposure and Cardiac Catheterization, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the ControlRad system device when installed in Fluoroscopic (x-ray) machine reduces radiation dose to operators (Doctors and nurses) and to the patient who is undergoing cardiac Catheterization and electrophysiology (EP) implant procedures.
Primary Outcome
Median effective radiation dose in microsievert (μSv) to the primary operator at the thyroid. This was measured using a RaySafe dosimeter to assess the radiation dose in each case.
Conditions Studied
Interventions
- RADIATION ControlRad System
- RADIATION Without ControlRad System
Study Locations (1)
Michigan
- Beaumont Hospital - Royal Oak - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2021-12-03 |
| Phase | NA |
What the finished NCT04404257 record still lists
NCT04404257 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, above the 26-participant average among 7 other Radiation Exposure trials with a reported enrollment target (554% higher).
The record links to 2 conditions, with Radiation Exposure appearing as the primary indexed condition, and to 2 interventions - of which ControlRad System is the first listed.
NCT04404257 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04404257 about?
NCT04404257 is a clinical study titled "Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation". The purpose of this study is to determine whether the ControlRad system device when installed in Fluoroscopic (x-ray) machine reduces radiation dose to operators (Doctors and nurses) and to the patient who is undergoing cardiac Catheterization and electrophysiology (EP) implant procedures.
What is the current status of trial NCT04404257?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2020-11-05. Estimated completion is 2021-12-03.
What conditions does trial NCT04404257 study?
This clinical trial studies the following conditions: Radiation Exposure, Cardiac Catheterization.
What interventions are being tested in trial NCT04404257?
The interventions under investigation include: ControlRad System (RADIATION), Without ControlRad System (RADIATION).
Who is sponsoring clinical trial NCT04404257?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404257 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
RECRUITING · NA
-
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
RECRUITING · NA
-
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
RECRUITING
-
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites
COMPLETED
-
A Prospective Study of Radiation Exposure to Surgeons
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI